Ropes & Gray advised Kailera Therapeutics, Inc. on the transaction. Kailera Therapeutics, Inc. (“Kailera”) announced raising $400 million in Series A financing. Kailera announced its launch...
Kailera Therapeutics’ $400 Million Series A Financing
FirstLight Fiber’s $120 Million Debt Financing
Ropes & Gray represented FirstLight Fiber and Antin Infrastructure Partners in the transaction, and Milbank represented Sixth Street and Palistar Capital. FirstLight Fiber, the Northeast U.S.’s...
Blackstone Secured Lending Fund’s $400 Million Unsecured Notes Offering
Simpson Thacher & Bartlett represented Blackstone Secured Lending Fund in the offering, and Ropes & Gray represented the underwriters. Blackstone Secured Lending Fund (NYSE: BXSL), a...
Insight Partners’ $1.5 Billion Continuation Fund III
Willkie Farr & Gallagher advised Insight Partners on the deal, and Ropes & Gray advised HarbourVest Partners. Insight Partners announced the closing of Continuation Fund III,...
Arthur J. Gallagher & Co.’s Acquisition of Risk International
Ropes & Gray represented BV Investment Partners in the transaction. Arthur J. Gallagher & Co. (NYSE:AJG) announced that its alternative risk and capital solutions subsidiary, Artex,...
Milk Specialties’ $300 Million Dividend Recapitalization
Kirkland & Ellis advised Milk Specialties Global on the transaction. Milk Specialties Global (“Milk Specialties”), a manufacturer of nutritional ingredients for the health and wellness, announced...
KinderCare Learning Companies’ $576 Million IPO
Ropes & Gray advised Partners Group Holding AG and KinderCare Learning Companies in the transaction. KinderCare Learning Companies (“KinderCare”) announced its $576 million initial public offering....
VodafoneZiggo’s €575 Million Green Bond
Ropes & Gray advised VodafoneZiggo on the transaction. VodafoneZiggo announced the issuance of €575 million of Senior Secured Notes due 2032, in accordance with VodafoneZiggo’s existing...
MOMA Therapeutics’ Collaboration and License Agreement with Bayer
Ropes & Gray advised MOMA Therapeutics on the transaction. MOMA Therapeutics announced it has entered into a collaboration and exclusive license agreement with Bayer to develop...
CAMP4 Therapeutics’ $75 Million IPO
Ropes & Gray represented CAMP4 Therapeutics in the transaction, and Paul Hastings represented the underwriters. CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company, announced...
DIRECTV’s Acquisition of EchoStar’s Video Distribution Business
Ropes & Gray represented DIRECTV Entertainment Holdings, LLC in the transaction, and White & Case represented EchoStar Corporation. DIRECTV (the “Company”) and EchoStar (NASDAQ: SATS) announced...
TPG’s Acquisition of AT&T’s 70% Stake in DIRECTV
Ropes & Gray, Cleary Gottlieb Steen & Hamilton and Mintz, Levin are advising TPG on the transaction. TPG (NASDAQ: TPG), a leading global alternative asset management...